Clinical Trials Logo

Filter by:
NCT ID: NCT02591017 Terminated - Clinical trials for Cancer: Extreme Pain on Movement

Comparison of Oral Morphine Versus Nasal Ketamine Spray With Chitosan in Cancer Pain Outpatients

ONKEMI
Start date: February 2015
Phase: Phase 3
Study type: Interventional

34 adult (>18 years) cancer pain outpatients with Opioid base therapy because of pain and breakthrough pain or extreme pain on movement will be included in this prospective, randomized, double-blind crossover study. Over a period of 3 weeks patients will go through 3 treatment arms, each one lasting one week: Group A receives morphine drops and Placebo spray, Group B receives ketamine/chitosan spray nasal and Placebo drops and Group C receives morphine drops and ketamine/chitosan spray nasal. Primary endpoint is time to onset of action of intranasal ketamine compared with morphine drops. Secondary endpoint is the median numeric rating scale (NRS) improvement after using the spray or morphine or the combination of ketamine spray and morphine drops.

NCT ID: NCT02590783 Terminated - Pelvic Pain Clinical Trials

Treatment of Pelvic Ring Fractures in the Elderly

Start date: October 17, 2017
Phase: N/A
Study type: Interventional

Pelvic ring fractures in the elderly are associated with high morbidity during standard conservative treatment due to immobility. Furthermore the risk of long term dependence even after the fracture has united is high. In analogy to the treatment of hip fractures in a similar patient population, patients might benefit from surgical treatment due to a reduction in pain and early mobilization.

NCT ID: NCT02589587 Completed - Obesity Clinical Trials

Enteroendocrine Cells Before and After Sleeve Gastrectomy

Start date: October 2013
Phase: N/A
Study type: Interventional

Morbidly obese patients exhibit impaired secretion of satiation hormones which may contribute to the development of obesity. Bariatric surgery is associated with weight loss and dramatic increase in the secretion of satiation hormones, but the underlying mechanism remains unknown. The investigator's goal is therefore to examine patients before and after sleeve gastrectomy and compare findings to lean controls.

NCT ID: NCT02589418 Completed - Clinical trials for Experimental Dental Pain

Mechanisms of Acupuncture Analgesia on Experimental Dental Pain - A Psychophysical Study (Phase1)

MAC-DENT1
Start date: October 2015
Phase: N/A
Study type: Interventional

The investigators will assess the effects of manual acupuncture on experimental dental pain in 36 healthy subjects by means of subjective pain intensity ratings and pain-specific autonomic nervous system (ANS) reactions.

NCT ID: NCT02589379 Recruiting - Pancreatic Fistula Clinical Trials

Ultrasound Elastography for Prediction of Postoperative Pancreatic Fistula

PMPPOPF
Start date: July 2015
Phase: N/A
Study type: Observational

The purpose of this study is to assess the value of preoperative objective modalities such as endoscopic ultrasound elastography and magnet resonance imaging in predicting development of postoperative pancreatic fistula in patients undergoing pancreatic surgery for benign or malignant disease.

NCT ID: NCT02587260 Completed - Clinical trials for Cardiovascular Diseases

Hunting for the Off-Target Properties of Ticagrelor on Endothelial Function in Humans (HI-TECH)

HI-TECH
Start date: December 17, 2015
Phase: Phase 4
Study type: Interventional

The purpose of this randomized, cross-over study, is to ascertain if ticagrelor, but not prasugrel or clopidogrel, is associated to an improved endothelial function as assessed with peripheral arterial tonometry and markers of endothelial function measurement in post-ACS patients.

NCT ID: NCT02585960 Completed - Hemophilia A Clinical Trials

BAX 855 PK-guided Dosing

PROPEL
Start date: November 23, 2015
Phase: Phase 3
Study type: Interventional

1. To compare the efficacy and safety of pharmacokinetic (PK)-guided treatment with BAX 855 targeting FVIII trough levels of 1-3% and approximately 10% (8-12%) 2. To further characterize pharmacokinetic (PK) and pharmacodynamic (PD) parameters of BAX 855

NCT ID: NCT02585778 Completed - Clinical trials for Hypercholesterolaemia

Efficacy and Safety of Alirocumab Versus Placebo on Top of Maximally Tolerated Lipid Lowering Therapy in Patients With Hypercholesterolemia Who Have Type 1 or Type 2 Diabetes and Are Treated With Insulin (ODYSSEY DM - Insulin)

Start date: October 23, 2015
Phase: Phase 3
Study type: Interventional

Primary Objectives: - To demonstrate the superiority of alirocumab in comparison with placebo in the reduction of calculated low-density lipoprotein cholesterol (LDL-C) in participants with diabetes treated with insulin and with hypercholesterolemia at high cardiovascular risk not adequately controlled on maximally tolerated LDL-C lowering therapy. - To evaluate the safety and tolerability of alirocumab in participants with diabetes treated with insulin. Secondary Objective: To demonstrate that alirocumab was superior in comparison to placebo in its effects on other lipid parameters (i.e., measured LDL-C, non-high-density lipoprotein cholesterol [non-HDL-C], apolipoprotein B [Apo B], total cholesterol [TC], lipoprotein a [Lp(a)], high density lipoprotein cholesterol [HDL-C], triglyceride [TG] levels, triglyceride rich lipoproteins [TGRL], apolipoprotein A-1 [Apo A-1], apolipoprotein C-III [Apo C-III], and LDL particle number and size).

NCT ID: NCT02585661 Completed - Healthy Volunteers Clinical Trials

Iron Bioavailability From Dairy Product

Start date: October 2015
Phase: N/A
Study type: Interventional

Determination of fractional iron absorption from dairy product fortified with 2 labelled iron compounds

NCT ID: NCT02585362 Completed - Breast Cancer Clinical Trials

Whey Protein Supplement in Combination With Physical Exercise and Nutrition Program

Start date: March 2016
Phase: N/A
Study type: Interventional

This study evaluates physical performance in cancer outpatients during a multimodal therapy. Half of the patients will receive physical exercise und nutrition program in combination with a specially formulated whey protein supplement, while the other half will receive standard care.